Celanese Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $9.7B-5.4% YoYTTM through 30 Jun 2026
Net Income -$1.2BTTM through 30 Jun 2026
Free Cash Flow $708MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 20.5% |
| EBITDA Margin | 1.5% |
| Operating Margin | -8.2% |
| Net Margin | -12.0% |
Returns
-28.8%ROE
-5.4%ROA
Balance Sheet Health
Debt / Equity3.11x
Current Ratio1.55x
Net Debt$11.3B
Cash & Equivalents$1.4B
Quality Metrics
Altman Z-Score1.28
Piotroski F-Score5 / 9
FCF Margin7.3%
Rule of 4010.3
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $9.5B
Diluted EPS-$10.68TTMFY2025: $-10.64
Dividend
$0.06Per share, FY20260.13%Yield-53.4%5-yr growth
Capital Allocation
R&D Spend$120M
Capex Intensity2.8%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Engineered Materials | $5.4B | -4.0% | View detailsFocused on complexity reduction, footprint optimization (including Lanaken, Belgium closure), and pipeline enrichment to steady margins. |
| Acetyl Chain | $4.2B | -11.0% | View detailsUtilizing daily operating model to optimize production at low-cost U.S. sites and align global distribution costs with demand. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.